Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Role of Real-World Evidence in CMS Price Ne...
By
Melike Belenli Gümüş
June 28, 2024
Introduction The role of real-world evidence (RWE) in the
Enhancing Global Health through Cost-Effectiveness Analysis
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Economic Benefits of Preventive Health Programs
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Brucellosis Control in Armenia: A Holistic Approach
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
« Previous
1
…
25
26
27
28
29
…
49
Next »